Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom

Santiago Perez-Lloret, Nikolai Petrovsky, Abdallah Alami, James A.G. Crispo, Donald Mattison, Matilde Otero-Losada, Francisco Capani, Daniel Krewski
doi: https://doi.org/10.1101/2021.09.28.21264245

Data Availability

The data from this study can be accessed at the Medicines and Healthcare products Regulatory Agency website

https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting

Back to top
Posted October 01, 2021.
Download PDF
Data/Code
Email
Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom
Santiago Perez-Lloret, Nikolai Petrovsky, Abdallah Alami, James A.G. Crispo, Donald Mattison, Matilde Otero-Losada, Francisco Capani, Daniel Krewski
medRxiv 2021.09.28.21264245; doi: https://doi.org/10.1101/2021.09.28.21264245
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area